Company Filing History:
1 out of 2,016 
1 out of 990 
1 out of 902 
Years Active: 2019
Title: Adam Mefferd: Innovator in Viral Inactivation Technologies
Introduction
Adam Mefferd is a notable inventor based in Durham, NC (US), recognized for his contributions to the field of viral inactivation technologies. With a focus on innovative solutions to combat viral infections, he has developed significant methodologies that enhance our understanding and treatment of viral diseases.
Latest Patents
Adam Mefferd holds a patent titled "Compositions for the inactivation of virus replication and methods of making and using the same." This patent includes recombinant constructs, vectors, and expression cassettes that utilize a tRNA promoter connected to a polynucleotide encoding a single guide RNA and a Cas9 polypeptide. The invention aims to inhibit viral replication and treat viral infections or viral-induced cancers through advanced genetic engineering techniques.
Career Highlights
Throughout his career, Adam has worked with prestigious institutions such as Duke University and Emory University. His work has significantly contributed to the advancement of viral research and therapeutic strategies, showcasing his commitment to innovation in the scientific community.
Collaborations
Adam has collaborated with esteemed colleagues, including Bryan R. Cullen and E. Matthew Kennedy. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Adam Mefferd's work exemplifies the intersection of innovation and science, particularly in the realm of viral inactivation technologies. His contributions continue to pave the way for advancements in medical research and treatment methodologies.